$23.16
-1.29-5.30%
Last update: 3:07 PM
15 minutes delayed
Comments
Loading...
Bicara Therapeutics (BCAX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary
Bicara Therapeutics Stock (NASDAQ: BCAX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bicara Therapeutics (BCAX) stock?
You can purchase shares of Bicara Therapeutics (NASDAQ:BCAX) through any online brokerage.
Who are Bicara Therapeutics (BCAX) competitors?
Other companies in Bicara Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Syndax Pharmaceuticals (NASDAQ:SNDX) and Arcutis Biotherapeutics (NASDAQ:ARQT).
What is the forecast, or price target, for Bicara Therapeutics (BCAX) stock?
Bicara Therapeutics has a consensus price target of $41.00.
What is the current price for Bicara Therapeutics (BCAX)?
The stock price for Bicara Therapeutics (NASDAQ: BCAX) is $23.155 last updated October 8, 2024 at 3:07 PM EDT.
Does Bicara Therapeutics (BCAX) pay a dividend?
There are no upcoming dividends for Bicara Therapeutics.
When is Bicara Therapeutics (NASDAQ:BCAX) reporting earnings?
Bicara Therapeutics’s Q3 earnings are confirmed for Saturday, November 16, 2024.
Is Bicara Therapeutics (BCAX) going to split?
There is no upcoming split for Bicara Therapeutics.
What sector and industry does Bicara Therapeutics (BCAX) operate in?
Bicara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.